Argenx
ARGX
#546
Rank
S$47.99 B
Marketcap
$786.09
Share price
0.70%
Change (1 day)
56.52%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -$5.63

According to Argenx 's latest financial reports the company's current EPS (TTM) is -$5.45. In 2022 the company made an earnings per share (EPS) of -$17.19.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.63-67.26%
2022-$17.19